Heart Transplant Global Market Analysis, Trends, Growth, Research And Forecast 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Heart Transplant Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $16.45 billion In 2028 At A CAGR Of 9.4% :

The heart transplant market size has grown rapidly in recent years. It will grow from $10.4 billion in 2023 to $11.49 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to medical advancements, increased awareness and education, advancements in organ preservation, healthcare infrastructure.

The heart transplant market size is expected to see strong growth in the next few years. It will grow to $16.45 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to government support and funding, globalization of transplant programs, increasing transplant center capacity, integration of telemedicine and remote monitoring. Major trends in the forecast period include technological advancements, artificial heart and assist devices, artificial intelligence (ai) in donor organ selection.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12967&type=smp

Heart Transplant Market Major Segments
The heart transplant market covered in this report is segmented -

1) By Surgery Type: Total Artificial Heart; Biventricular Pacing; Ventricular Assist Devices; Other Surgery Types
2) By Transplant: Autograft; Allograft; Other Transplants
3) By End-User: Hospitals; Cardiac Institutes; Other End-Users

Key Driver - Growth Of The Heart Transplant Market Fuels By Increasing Prevalence Of Cardiovascular Diseases

The prevalence of cardiovascular diseases is expected to propel the growth of the heart transplant market going forward. Cardiovascular diseases are a range of conditions that affect the heart and blood arteries. A heart transplant is a last-resort treatment for people with end-stage heart failure who have not responded to other treatments. It improves quality of life and extends life expectancy. For instance, in March 2022, according to the Office for National Statistics, a UK-based national statistical authority, the number of deaths due to heart attacks was 20,061 in 2021, increasing from 19,440 in 2020. Further, in May 2023, the Centers for Disease Control and Prevention., a US-based national public health agency, reported that in the US, 1 in 20 adults age 20 and older have cardiovascular diseases, and 695,000 people were suffering from cardiovascular diseases in 2021 and 375,476 people died with cardiovascular diseases that same year. Therefore, the prevalence of cardiovascular diseases will drive the heart transplant market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12967&type=smp

Prominent Trend - Innovation In Heart Transplant Assessment

Major market players are concentrating on creating innovative test-treatment technologies to sustain their position in the market. Prospera Heart Transplant Assessment Test is a non-invasive blood test that measures the amount of donor-derived cell-free DNA (dd-cfDNA) in the recipient's blood. For instance, in August 2021, Natera Inc., a US-based clinical genetic testing company, launched its Prospera heart transplant assessment test for heart patients who received a transplant, validating and clinically releasing it. This innovative test represents the first significant application of prospera technology beyond kidney transplants and leverages Natera's expertise from performing more than 3 million cell-free deoxyribonucleic acid (cfDNA) tests worldwide. Additionally, it provides a non-invasive, single-test solution for assessing acute rejection, which can help improve the diagnosis and management of this condition. The test is also expected to reduce the cost of care for heart transplant recipients.

Heart Transplant Market Players
Major players in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the heart transplant market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Heart Transplant Market Report Structure
3. Heart Transplant Market Trends And Strategies
4. Heart Transplant Market - Macro Economic Scenario
5. Heart Transplant Market Size And Growth
…..
27. Heart Transplant Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.